Skip to content

A randomised multiple centre trial of conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU)

A randomised multiple centre trial of conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN92103439
Enrollment
2040
Registered
2020-01-07
Start date
2020-02-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical care Not Applicable

Interventions

The researchers will recruit 2040 patients from 15 paediatric critical care units and their associated specialist retrieval services (teams of doctors and nurses that attend local hospitals to assist

Sponsors

Intensive Care National Audit and Research Centre (ICNARC)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >38 weeks corrected gestational age and <16 years 2. Unplanned PICU referral 3. Commenced on invasive mechanical ventilation with supplemental oxygen 4. Within 6 hours of face-to-face contact with PICU staff or retrieval team

Exclusion criteria

Exclusion criteria: 1. Death perceived as imminent 2. Brain pathology/injury as primary reason for admission 3. Known pulmonary hypertension 4. Known or suspected uncorrected congenital cardiac disease 5. Known sickle cell disease 6. End-of-life care plan in place with limitation of resuscitation 7. Receiving long-term mechanical ventilation prior to this admission 8. Recruited to Oxy-PICU in a previous admission

Design outcomes

Primary

MeasureTime frame
1. A composite of mortality and days of organ support at 30 days assessed through review of patient medical notes and/or data-linkage with nationally held death registrations (clinical effectiveness) 2. Incremental costs, quality-adjusted life years and net monetary benefit assessed using age-appropriate Pediatric Quality of Life Inventory (Peds-QL) and the Child Health Utility 9D (CHU-9D) at 12 months (cost effectiveness)

Secondary

MeasureTime frame
Current secondary outcome measures as of 09/11/2022: 1. Incremental costs calculated from patient-level resource data, length of stay in PICU/HDU and acute hospital for the index admission and any re-admission before 30 days after randomisation 2. Mortality assessed via patient medical notes and/or data linkage with nationally held death registrations at PICU discharge, 30 days, 90 days and 12 months 3. Time to liberation from mechanical ventilation, defined as the time the child was extubated and remained so for the remainder of their PICU stay 4. Duration of organ support during the child’s PICU stay 5. Functional status at PICU discharge as assessed by a clinician using the Paediatric Cerebral Performance Category (PCPC) and Paediatric Overall Performance Category (POPC) scales using patient’s notes 6. Duration of PICU and hospital stay assessed through review of patient medical notes at PICU discharge and hospital discharge 7. HrQoL at 12 months, measured by the child, self-or parent-proxy reported PedsQL-4.0 and the Child Heath Utility 9D (CHU-9D) at 12 months post randomisation Previous secondary outcome measures: 1. Mortality assessed via patient medical notes and/or data linkage with nationally held death registrations at PICU discharge, 30 days, 90 days and 12 months 2. Time to liberation from mechanical ventilation defined as the time the child was extubated and remained so for the remainder of their PICU stay 3. Duration of organ support during the child’s PICU stay 4. Duration of PICU and hospital stay assessed through review of patient medical notes at PICU discharge and hospital discharge

Countries

England, United Kingdom

Contacts

Public ContactPaul Mouncey
oxypicu@icnarc.org+44 (0)20 7831 6879

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026